colorectal-cancer

Documents about colorectal-cancer

• Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients#811109ClinicalTrials.gov
• A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC#826361ClinicalTrials.gov
• A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification#805511ClinicalTrials.gov
• Improving Colorectal Cancer Screening Rates in Underserved Adults in Primary Care at a Federally Qualified Health Care Center Using an “At-Home” Screening Approach: An Evidence-based Quality Improvement Project#168913DigitalCommons@SHU
• Hemorrhage-coagulation immune phenotype is associated with CD163/HO-1-enriched heme-processing macrophage remodeling and predicts recurrence in colorectal cancer: a real-world retrospective cohort study.#368198NCBI PubMed Central
• Functional and Participation Outcomes of Colorectal Cancer With Peritoneal Metastasis and Pseudomyxoma Peritonei Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC): A Cross-Sectional Survivorship Study.#378574NCBI PubMed Central
• Deprived social status is associated with decreased use of oral chemotherapy in patients with metastatic colorectal cancer: A retrospective cohort study on administrative databases in a French University Hospital#670131HAL (France)
• Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors#804159ClinicalTrials.gov
• The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.#800389ClinicalTrials.gov
• Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study#326116HAL (France)
• Initial Development of a Brief Mind-Body Sexual Well-Being Program for Female Colorectal and Anal Cancer Survivors: A Two-Phase Study of Survivor Needs and Treatment Preferences.#399588NCBI PubMed Central
• A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.#666090NCBI PubMed Central
• Risk stratification by minimal residual disease detection and ctDNA dynamics from personalised assays in stage II-III colorectal cancer in a UK multi-centre prospective study (TRACC Part B)#5065Europe PMC
• A nomogram based on dual-layer spectral detector CT-derived 40-KeV virtual monoenergetic images and iodine maps for preoperative prediction of regional lymph node metastasis in colorectal cancer.#165637NCBI PubMed Central
• Longitudinal Associations Between Inflammatory Markers at 12‐Months and Three Core Symptoms of Depression at 12‐ and 24‐Months After Colorectal Cancer Diagnosis: Results From the Population‐Based PROFILES Registry.#382406NCBI PubMed Central
• Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC#812102ClinicalTrials.gov
• Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer#814598eScholarship
• Association between body mass index and major cancers with a focus on breast in South and Southeast Asia: A regional systematic review and meta-analysis#418040IRIS
• In-silico identification of bacterial key-genes directly or indirectly associated with the development and progression of colorectal cancer for exploring anti-bacterial agents#316317PLOS
• HIF-1α integrates lipogenic FASN and glycolytic GLUT3 to overcome intratumor oxidative and hypoxic stress for colorectal cancer metastasis#323996Springer Nature OA
• Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)#326136HAL (France)
• The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)#454019ClinicalTrials.gov
• Heterozygous germline <i>MSH3</i> mutations, and probably <i>MLH3</i> mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk#475780Europe PMC
• Chewing Gum Flavors to Reduce Postoperative Nausea and Vomiting After PIPAC#801508ClinicalTrials.gov
• First in Human Study of AZD9592 in Solid Tumors#803531ClinicalTrials.gov
• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)#162475ClinicalTrials.gov
• Targeting Ion Channel Dysregulation in Colorectal Cancer: Identification of Clofilium as a Potent Inhibitor of Tumor Growth and Metastatic Potential#141279OSF
• Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study#326317HAL (France)
• Letter to the editor: Faecal Immunochemical Test (FIT) sensitivity: a five year audit#654960Spiral
• Comparison of an ensemble machine learning model to a Cox regression model to predict colorectal cancer risk among people with HIV using retrospective nationwide cohort data in Sweden: a study protocol.#685851NCBI PubMed Central
• A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.#828040ClinicalTrials.gov
• Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors#180367ClinicalTrials.gov
• Additional file 2 of A cost comparison between patients undergoing robotic colorectal surgery with and without a clinical pathway#221753Figshare
• Additional file 1 of A cost comparison between patients undergoing robotic colorectal surgery with and without a clinical pathway#221756Figshare
• Targeting Ion Channel Dysregulation in Colorectal Cancer: Identification of Clofilium as a Potent Inhibitor of Tumor Growth and Metastatic Potential#15769OSF
• Kemoterapi alan kolorektal kanserli hastalara Levine Koruma Modeline dayalı uygulanan hemşirelik girişimlerinin yorgunluk, periferal nöropati ve kaygı düzeyine etkisi: Randomize kontrollü çalışma#260223Necmettin Erbakan University Institutional Repository
• Dual immunosuppression mechanism induced by PTP1B in colorectal cancer: upregulation of PD-L1 by FOXO1/miR-34C/c-MYC axis and inhibition of the infiltration of CD8(+) T cell by downregulating of CXCL11.#285134NCBI PubMed Central
• Proteomic analysis of saliva reveals changes in proteomic profiles during colorectal cancer in an Iranian cohort / Sama Rezasoltani, Ali Biabani, Bente Siebels, Hamid Asadzadeh Aghdaei, Georg Conrads, Hartmut Schlüter, Mohammad Mehdi Feizabadi#629084Deutsche Nationalbibliothek
• Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial#670104HAL (France)
• Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial#829862ClinicalTrials.gov
• The Impact of Patient Complexity on Healthcare Utilization#343758ClinicalTrials.gov
• A Whole Genomic CRISPR/Cas9 Screen Identifies the Amino Acid Transporter SLC43A1 (LAT3) as a Major Determinant of Oxaliplatin Sensitivity in Colorectal Cancer Cells#485210Europe PMC
• Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors#825504ClinicalTrials.gov
• Etude de l'action de la vitamine A sur le risque de cancer colique lié à une surcharge lipidique#330234HAL (France)
• Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)#813854ClinicalTrials.gov
• Characterization of human isogenic epithelial cell lines as a relevant tool to study colon carcinogenesis and interactions between genes and environment#330339HAL (France)
• Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR#247936Open Access LMU
• Unmet social needs and colorectal cancer testing at 45-49 since the 2021 USPSTF recommendation#683846eScholarship
• First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)#159265HAL (France)
• Maintenance of p-eIF2α levels by the eIF2B complex is vital for colorectal cancer / Ivana Paskov Škapik, Chiara Giacomelli, Sarah Hahn, Hanna Deinlein, Peter Gallant, Mathias Diebold, Josep Biayna, Anne Hendricks, Leon Olimski, Christoph Otto, Carolin Kastner, Elmar Wolf, Christina Schülein-Völk, Katja Maurus, Andreas Rosenwald, Nikolai Schleussner, Rene-Filip Jackstadt, Nicolas Schlegel, Christoph-Thomas Germer, Martin Bushell, Martin Eilers, Stefanie Schmidt, Armin Wiegering#783900Deutsche Nationalbibliothek